China Regenerative Medicine International Limited (HKG:8158)
0.2320
+0.0120 (5.45%)
Aug 4, 2026, 11:43 AM HKT
China Regenerative Medicine International Employees
China Regenerative Medicine International had 30 employees as of December 31, 2025. The number of employees decreased by 6 or -16.67% compared to the previous year.
Employees
30
Change
-6
Growth
-16.67%
Revenue / Employee
2.40M HKD
Profits / Employee
917.50K HKD
Market Cap
66.94M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 30 | -6 | -16.67% | 30 | 0 |
| Jun 30, 2025 | 24 | - | - | 24 | 0 |
| Dec 31, 2024 | 36 | -10 | -21.74% | 34 | 2 |
| Dec 31, 2023 | 46 | 23 | 100.00% | 42 | 4 |
| Dec 31, 2022 | 23 | 2 | 9.52% | 20 | 3 |
| Jun 30, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 21 | -151 | -87.79% | 18 | 3 |
| Jun 30, 2021 | 24 | -345 | -93.50% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 543 |
| JW (Cayman) Therapeutics Co. | 314 |
| Immunotech Biopharm | 183 |
| 3D Medicines | 162 |
| Transcenta Holding | 155 |
| Kintor Pharmaceutical | 123 |
| Wuhan YZY Biopharma | 106 |
| Brii Biosciences | 75 |